This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 93/2/162    most recent 01.RES.0000082980.94211.3Av1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Goukassian, D. A. Articles by Losordo, D. W. Search for Related Content PubMed PubMed Citation Articles by Goukassian, D. A. Articles by Losordo, D. W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Related Collections Restenosis Apoptosis Growth factors/cytokines Endothelium/vascular type/nitric oxide

(Circulation Research. 2003;93:162.)
© 2003 American Heart Association, Inc.

Molecular Medicine

Engineering the Response to Vascular Injury

Divergent Effects of Deregulated E2F1 Expression on Vascular Smooth Muscle Cells and Endothelial Cells Result in Endothelial Recovery and Inhibition of Neointimal Growth

David A. Goukassian, Raj Kishore, Kevin Krasinski, Christine Dolan, Corinne Luedemann, Young-sup Yoon, Marianne Kearney, Allison Hanley, Hong Ma, Takayuki Asahara, Jeffrey M. Isner, Douglas W. Losordo

From the Department of Medicine, Division of Cardiovascular Research (D.A.G., R.K., K.K., C.D., C.L., Y.-s.Y., M.K., A.H., H.M., T.A., J.M.I., D.W.L.), St Elizabeth’s Medical Center, Boston, Mass; and the Department of Dermatology (D.A.G.), Boston University School of Medicine, Boston, Mass.

Correspondence to Douglas W. Losordo, MD, Division of Cardiovascular Medicine, St Elizabeth’s Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail douglas.losordo{at}tufts.edu

Tumor necrosis factor- (TNF-) is expressed locally in the vessel wall after angioplasty and induces growth arrest and apoptosis in endothelial cells (ECs), thereby delaying reendothelialization. Prior studies have shown that direct antagonism of TNF-, using a systemically administered soluble receptor, can enhance endothelial recovery and reduce neointimal thickening. These studies have also shown that downregulation of the transcription factor E2F1 was a key mechanism of TNF’s effect on ECs. We now show that Ad-E2F1 overexpression at sites of balloon injury accelerates functional endothelial recovery, consistent with the prior in vitro findings. Moreover these studies also reveal divergent effects of TNF- and overexpression of E2F1 on ECs versus VSMCs. TNF- exposure of VSMCs had no affect on proliferation or apoptosis, in contrast to the effect seen in ECs. In Ad-E2F1-transduced VSMCs, however, TNF--induced marked apoptosis in contrast to the survival effect seen in ECs. Finally, these studies suggest that differential activation of NF-B may play a key role in mediating these opposing effects. Nuclear translocation and transcriptional activity of NF-B was markedly attenuated in Ad-E2F1-transduced VSMCs, whereas it remained active in similarly treated ECs when the cells were exposed to TNF-. These studies reveal that overexpression of Ad-E2F1 primes VSMCs to TNF--induced apoptosis. Furthermore, E2F1 potentiates VSMC death by blocking antiapoptotic signaling pathway through inhibition of NF-B activation. The divergent responses of VSMCs and ECs to E2F1 overexpression provide unique therapeutic possibilities: simultaneously targeting the cell cycle of two different cell types, within same tissue microenvironment resulting in opposite and biologically complimentary effects.

Key Words: apoptosis • vascular smooth muscle cells • E2F1 • tumor necrosis factor- • nuclear factor-B

This article has been cited by other articles:

				D. A. Goukassian, G. Qin, C. Dolan, T. Murayama, M. Silver, C. Curry, E. Eaton, C. Luedemann, H. Ma, T. Asahara, et al. Tumor Necrosis Factor-{alpha} Receptor p75 Is Required in Ischemia-Induced Neovascularization Circulation, February 13, 2007; 115(6): 752 - 762. [Abstract] [Full Text] [PDF]

				G. Qin, R. Kishore, C. M. Dolan, M. Silver, A. Wecker, C. N. Luedemann, T. Thorne, A. Hanley, C. Curry, L. Heyd, et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF PNAS, July 18, 2006; 103(29): 11015 - 11020. [Abstract] [Full Text] [PDF]

				G. Qin, M. Ii, M. Silver, A. Wecker, E. Bord, H. Ma, M. Gavin, D. A. Goukassian, Y.-s. Yoon, T. Papayannopoulou, et al. Functional disruption of {alpha}4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization J. Exp. Med., January 23, 2006; 203(1): 153 - 163. [Abstract] [Full Text] [PDF]

				A. Iwakura, C. Luedemann, S. Shastry, A. Hanley, M. Kearney, R. Aikawa, J. M. Isner, T. Asahara, and D. W. Losordo Estrogen-Mediated, Endothelial Nitric Oxide Synthase-Dependent Mobilization of Bone Marrow-Derived Endothelial Progenitor Cells Contributes to Reendothelialization After Arterial Injury Circulation, December 23, 2003; 108(25): 3115 - 3121. [Abstract] [Full Text] [PDF]

				R. Kishore, C. Luedemann, E. Bord, D. Goukassian, and D. W. Losordo Tumor Necrosis Factor-Mediated E2F1 Suppression in Endothelial Cells: Differential Requirement of c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Signal Transduction Pathways Circ. Res., November 14, 2003; 93(10): 932 - 940. [Abstract] [Full Text] [PDF]